Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.54B |
| Enterprise Value | 3.66B |
| P/E Ratio | 22.17 |
| PEG Ratio | 2.31 |
| Price/Sales Ratio | 2.44 |
| Price/Book Ratio | 1.91 |
| Enterprise/Revenue | 2.59 |
| Enterprise/EBITDA | 12.33 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 1.34B |
| Revenue/Share | 10.34 |
| Gross Profit | 380M |
| EBITDA | 316.04M |
| Net Income | 150.97M |
| Diluted EPS | 1.11 |
Balance Sheet
| Total Cash | 212.18M |
| Total Cash/Share | 1.57 |
| Total Debt | 416.42M |
| Total Debt/Equity | 0.23 |
| Current Ratio | 1.27 |
| Book Value Per Share | 13.28 |
Price History
| 52-Week Change | -11.83 |
| 52-Week High | 30.8 |
| 52-Week Low | 21.9 |
| Moving Average 50 Days | 25.49 |
| Moving Average 200 Days | 26.18 |
Statistics
| Average Volume | 1.55M |
| Shares Outstanding | 135.44M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.6 |
| Trailing Annual Dividend Yield | 2.37 |
| Payout Ratio | 0.58 |
| Last Split Factor | 7:5 |
| Last Split Date | May 27, 2020 |
AD
